{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:45:41Z","timestamp":1776332741799,"version":"3.50.1"},"reference-count":32,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Introduction:<\/jats:title>\n<jats:p>Paracetamol (Acetaminophen) is a very common OTC drug that is found\nin more than 200 OTC products sold as pain, cough and cold remedies. Paracetamol is commonly\nused as an antipyretic to reduce fever and as an alternative to Non-steroidal anti-inflammatory\ndrugs (NSAIDs) that are contraindicated in certain patients to relieve mild-moderate pain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This review article focuses on SJS, TEN, SJS\/TEN overlap, AGEP, and DRESS syndromes\nassociated with the use of paracetamol or paracetamol-containing products.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>To find published articles relevant to paracetamol-associated SJS, TEN, AGEP, and\nDRESS, we searched the online databases Medline\/Pubmed\/PMC, Google Scholar, Science Direct,\nEbsco, Scopus, Web of Science, Embase, and reference lists using keywords like Stevens-Johnson\nSyndrome, Acetaminophen, Paracetamol, Toxic epidermal necrolysis, Acute generalized exanthematous\npustulosis, Drug reaction with eosinophilia and systemic symptoms.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The paracetamol-associated SJS, TEN, SJS\/TEN overlap, AGEP, and DRESS syndromes\nhave been identified by a number of publications.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>When evaluating drug-induced hypersensitivity skin reactions, healthcare professionals,\nincluding prescribers, pharmacists, and others, should be aware of this rare risk. Patients who\nexhibit signs and symptoms of paracetamol-associated hypersensitivity should be referred to physicians\nby pharmacists for further treatment. At the first sign of a skin rash or other hypersensitivity\nreaction while taking paracetamol, patients should be told to stop taking it and see a doctor right\naway.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886318666230505144014","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T05:32:06Z","timestamp":1683523926000},"page":"218-223","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Paracetamol (Acetaminophen)-associated SJS, TEN, AGEP, and DRESS\nSyndromes - A Narrative Review"],"prefix":"10.2174","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6950-9783","authenticated-orcid":true,"given":"Naina Mohamed","family":"Pakkir Maideen","sequence":"first","affiliation":[{"name":"Department of Clininal Pharmacy, Dubai Academic Health Corporation\/Dubai Health Authority, Dubai, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim Ramadan","family":"Barakat","sequence":"additional","affiliation":[{"name":"Nursing Department, Dubai Academic Health Corporation\/Dubai Health Authority, Dubai, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AbduRazak Hassan","family":"Jumale","sequence":"additional","affiliation":[{"name":"Department of Medical Affairs, Dubai Academic Health Corporation\/Dubai Health Authority, Dubai, UAE"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2710.2009.01143.x","volume":"35","author":"Toussaint K.","year":"2010","unstructured":"Toussaint K.; Yang X.C.; Zielinski M.A.; What do we (not) know about how paracetamol (acetaminophen) works? J Clin Pharm Ther 2010,35(6),617-638","journal-title":"J Clin Pharm Ther"},{"key":"ref=2","first-page":"13","volume":"52","author":"Camu F.","year":"2001","unstructured":"Camu F.; Van de Velde A.; Vanlersberghe C.; Nonsteroidal anti-inflammatory drugs and paracetamol in children. Acta Anaesthesiol Belg 2001,52(1),13-20","journal-title":"Acta Anaesthesiol Belg"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1440-1681.13392","volume":"48","author":"Przyby\u0142a G.W.","year":"2021","unstructured":"Przyby\u0142a G.W.; Szychowski K.A.; Gmi\u0144ski J.; Paracetamol \u2013 An old drug with new mechanisms of action. Clin Exp Pharmacol Physiol 2021,48(1),3-19","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref=4","first-page":"11","volume":"71","author":"J\u00f3\u017awiak-Bebenista M.","year":"2014","unstructured":"J\u00f3\u017awiak-Bebenista M.; Nowak J.Z.; Paracetamol: Mechanism of action, applications and safety concern. Acta Pol Pharm 2014,71(1),11-23","journal-title":"Acta Pol Pharm"},{"key":"ref=5","first-page":"30","volume":"7","author":"Maideen N.M.P.","year":"2019","unstructured":"Maideen N.M.P.; Drug Interactions of acetaminophen (Paracetamol) involving CYP and UGT enzymes. Eur J Med 2019,7(1),30-34","journal-title":"Eur J Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"125","DOI":"10.4254\/wjh.v12.i4.125","volume":"12","author":"Rotundo L.","year":"2020","unstructured":"Rotundo L.; Pyrsopoulos N.; Liver injury induced by paracetamol and challenges associated with intentional and unintentional use. World J Hepatol 2020,12(4),125-136","journal-title":"World J Hepatol"},{"key":"ref=7","year":"2013","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication:\tFDA warns of rare but serious skin reactions with the pain reliever\/\tfever reducer acetaminophen 2013"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000335213","volume":"159","author":"Rutkowski K.","year":"2012","unstructured":"Rutkowski K.; Nasser S.M.; Ewan P.W.; Paracetamol hypersensitivity: Clinical features, mechanism and role of specific IgE. Int Arch Allergy Immunol 2012,159(1),60-64","journal-title":"Int Arch Allergy Immunol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.31128\/AJGP-08-18-4689","volume":"48","author":"Thompson G.","year":"2019","unstructured":"Thompson G.; Blundell C.; Lucas M.; Paracetamol allergy in clinical practice. Aust J Gen Pract 2019,48(4),216-219","journal-title":"Aust J Gen Pract"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/07853890701753664","volume":"40","author":"Hazin R.","year":"2008","unstructured":"Hazin R.; Ibrahimi O.A.; Hazin M.I.; Kimyai-Asadi A.; Stevens\u2010Johnson syndrome: Pathogenesis, diagnosis, and management. Ann Med 2008,40(2),129-138","journal-title":"Ann Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.survophthal.2016.01.004","volume":"61","author":"Jain R.","year":"2016","unstructured":"Jain R.; Sharma N.; Basu S.; Stevens-Johnson syndrome: The role of an ophthalmologist. Surv Ophthalmol 2016,61(4),369-399","journal-title":"Surv Ophthalmol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"588063","DOI":"10.3389\/fphar.2021.588063","volume":"12","author":"Cheng L.","year":"2021","unstructured":"Cheng L.; Current pharmacogenetic perspective on Stevens-Johnson syndrome and toxic epidermal necrolysis. Front Pharmacol 2021,12,588063","journal-title":"Front Pharmacol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"Mockenhaupt M.","year":"2008","unstructured":"Mockenhaupt M.; Viboud C.; Dunant A.; Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008,128(1),35-44","journal-title":"J Invest Dermatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/bcp.13445","volume":"84","author":"Lebrun-Vignes B.","year":"2018","unstructured":"Lebrun-Vignes B.; Guy C.; Jean-Pastor M.J.; Gras-Champel V.; Zenut M.; Is acetaminophen associated with a risk of stevens-johnson syndrome and toxic epidermal necrolysis? analysis of the french pharmacovigilance database. Br J Clin Pharmacol 2018,84(2),331-338","journal-title":"Br J Clin Pharmacol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/pharmacy7010012","volume":"7","author":"Popio\u0142ek I.","year":"2019","unstructured":"Popio\u0142ek I.; Piotrowicz-W\u00f3jcik K.; Porebski G.; Hypersensitivity reactions in serious adverse events reported for paracetamol in the EudraVigilance database, 2007\u20132018. Pharmacy 2019,7(1),12","journal-title":"Pharmacy"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1080\/15569527.2021.1942896","volume":"40","author":"Milosavljevi\u0107 M.N.","year":"2021","unstructured":"Milosavljevi\u0107 M.N.; Pej\u010di\u0107 A.V.; Milosavljevi\u0107 J.Z.; A review of published cases of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with the use of acetaminophen. Cutan Ocul Toxicol 2021,40(3),280-292","journal-title":"Cutan Ocul Toxicol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41439-019-0082-6","volume":"6","author":"Ueta M.","year":"2019","unstructured":"Ueta M.; Nakamura R.; Saito Y.; Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens\u2013Johnson syndrome with severe ocular complications in Japanese individuals. Hum Genome Var 2019,6(1),50","journal-title":"Hum Genome Var"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1136\/bjophthalmol-2020-317315","volume":"106","author":"Jongkhajornpong P.","year":"2022","unstructured":"Jongkhajornpong P.; Ueta M.; Lekhanont K.; Association of HLA polymorphisms and acetaminophen-related Steven-Johnson syndrome with severe ocular complications in Thai population. Br J Ophthalmol 2022,106(6),884-888","journal-title":"Br J Ophthalmol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.jaad.2015.07.017","volume":"73","author":"Szatkowski J.","year":"2015","unstructured":"Szatkowski J.; Schwartz R.A.; Acute generalized exanthematous pustulosis (AGEP): A review and update. J Am Acad Dermatol 2015,73(5),843-848","journal-title":"J Am Acad Dermatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/j.1365-2133.2007.08156.x","volume":"157","author":"Sidoroff A.","year":"2007","unstructured":"Sidoroff A.; Dunant A.; Viboud C.; Risk factors for acute generalized exanthematous pustulosis (AGEP)\u2014results of a multinational case\u2013control study (EuroSCAR). Br J Dermatol 2007,157(5),989-996","journal-title":"Br J Dermatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"4486","DOI":"10.3390\/jcm10194486","volume":"10","author":"Martinez-De la Torre A.","year":"2021","unstructured":"Martinez-De la Torre A.; van Weenen E.; Kraus M.; Weiler S.; Feuerriegel S.; Burden A.M.; A network analysis of drug combinations associated with acute generalized exanthematous pustulosis (AGEP). J Clin Med 2021,10(19),4486","journal-title":"J Clin Med"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1159\/000509712","volume":"3","author":"Sasi S.","year":"2020","unstructured":"Sasi S.; Altarawneh H.; Petkar M.A.; Nair A.P.; Drug reaction with eosinophilia and systemic symptoms secondary to naproxen: A case report and literature review. Case Rep Acute Med 2020,3(2),63-72","journal-title":"Case Rep Acute Med"},{"key":"ref=23","first-page":"AB39","volume":"62","author":"Jeffy B.","year":"2010","unstructured":"Jeffy B.; Calen J.P.; Waldman M.; Drug reaction with eosinophilia and systemic symptoms (DRESS) associated with acetaminophen and reactivation of HHV-6. J Am Acad Dermatol 2010,62(3),AB39","journal-title":"J Am Acad Dermatol"},{"key":"ref=24","first-page":"2366","volume":"94","author":"Shu C.","year":"2014","unstructured":"Shu C.; Qu T.; Jia L.; [Clinical characteristics of drug hypersensitivity syndrome in 10 patients Zhonghua Yi Xue Za Zhi 2014,94(30),2366-2368","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref=25","first-page":"246","volume":"32","author":"Tank N.D.","year":"2015","unstructured":"Tank N.D.; Karelia B.N.; Bhansali N.B.; Paracetamol induced drug reaction with eosinophilia and systemic symptoms (Dress syndrome): A case report. Int J Pharm Sci Rev Res 2015,32,246-248","journal-title":"Int J Pharm Sci Rev Res"},{"key":"ref=26","first-page":"110","volume":"19","author":"de Oliveira C.A.","year":"2021","unstructured":"de Oliveira C.A.; J\u00fanior R.F.; S\u00edndrome DRESS por paracetamol. Rev Soc Bras Clin Med 2021,19(2),110-115","journal-title":"Rev Soc Bras Clin Med"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.12809\/hkmj166186","volume":"23","author":"Lee Q.U.","year":"2017","unstructured":"Lee Q.U.; Hypersensitivity to antipyretics: Pathogenesis, diagnosis, and management. Hong Kong Med J 2017,23(4),395-403","journal-title":"Hong Kong Med J"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.clindermatol.2020.06.008","volume":"38","author":"Cardones A.R.","year":"2020","unstructured":"Cardones A.R.; Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. Clin Dermatol 2020,38(6),702-711","journal-title":"Clin Dermatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1542\/peds.2008-1923","volume":"123","author":"Levi N.","year":"2009","unstructured":"Levi N.; Bastuji-Garin S.; Mockenhaupt M.; Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: A pooled analysis. Pediatrics 2009,123(2),e297-e304","journal-title":"Pediatrics"},{"key":"ref=30","first-page":"379","volume":"105","author":"Gamba C.","year":"2014","unstructured":"Gamba C.; Schroeder J.; Citterio A.; Cazzaniga S.; Rivolta A.L.; Vighi G.;  Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia Recenti Prog Med 2014,105(10),379-384","journal-title":"Surveillance of severe cutaneous drug reactions: experience REACT-Lombardia Recenti Prog Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.4103\/0378-6323.110749","volume":"79","author":"Patel T.","year":"2013","unstructured":"Patel T.; Barvaliya M.; Sharma D.; Tripathi C.; A systematic review of the drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population. Indian J Dermatol Venereol Leprol 2013,79(3),389-398","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000487556","volume":"176","author":"Gabrielli S.","year":"2018","unstructured":"Gabrielli S.; Langlois A.; Ben-Shoshan M.; Prevalence of hypersensitivity reactions in children associated with acetaminophen: A systematic review and meta-analysis. Int Arch Allergy Immunol 2018,176(2),106-114","journal-title":"Int Arch Allergy Immunol"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230505144014","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/216598\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1574886318666230505144014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,13]],"date-time":"2023-12-13T12:19:55Z","timestamp":1702469995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/216598\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886318666230505144014","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-10-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}